Arlington Capital Partners Acquires Exostar from Thoma Bravo

Thoma Bravo Acquires Exostar

June 2, 2020

Cybersecurity

Thoma Bravo has completed a strategic growth investment to acquire Exostar, a provider of secure, cloud-based collaboration and identity access management solutions serving highly regulated industries. The investment will support Exostar's product and cybersecurity capability expansion and help accelerate growth across aerospace & defense, life sciences and healthcare markets.

DC Capital Partners Acquires AstreaX

May 10, 2024

Government & Public Sector

DC Capital Partners Management, LP has made a controlling investment in AstreaX, a provider of software development and implementation services for DMV and government IT modernization. The investment will support AstreaX's expansion of its IT modernization offerings, digital identity and super-portal solutions across additional state and provincial jurisdictions.

Thoma Bravo Acquires AxiomSL

October 19, 2020

Software

Thoma Bravo has agreed to acquire a controlling interest in AxiomSL, a provider of cloud-enabled risk management and regulatory reporting software for banks, investment managers, broker-dealers and trading firms. Thoma Bravo said it will partner with AxiomSL's management to accelerate product innovation, expand cloud capabilities and grow the company's customer base; the deal closed with financing from several lenders and advisors were Evercore and Weil, Gotshal & Manges for AxiomSL and Kirkland & Ellis for Thoma Bravo.

Thoma Bravo Backs Merger of OPEXUS and Casepoint

February 10, 2025

Software

Thoma Bravo has made a majority investment to back the merger of Casepoint and OPEXUS, creating a combined provider of data discovery and government process management software. Gemspring Capital sold OPEXUS to an affiliate of Thoma Bravo (retaining a minority stake), and Comvest Credit Partners and HarbourVest Partners provided debt financing for the transaction.

Arlington Capital Partners Makes Majority Investment in Everest Clinical Research Corporation

December 7, 2020

Healthcare Services

Washington, D.C.-based private equity firm Arlington Capital Partners has made a majority investment in Toronto-headquartered Everest Clinical Research Corporation, with Everest's founding shareholders and senior management rolling equity and continuing to lead the company. Everest is a full-service contract research organization (CRO) with ~300 employees across Toronto, Little Falls (NJ) and Shanghai; Arlington will support expansion of service lines, capabilities and headcount to drive growth.

BlueHalo Acquires Eqlipse Technologies

February 13, 2024

Aerospace & Defense

BlueHalo will acquire Eqlipse Technologies, combining two Arlington Capital Partners portfolio companies to create a larger defense technology platform. The combined company will be headquartered in Arlington, Virginia, employ nearly 2,400 people across 11 states, approach $1 billion in annual revenue, and expand BlueHalo's capabilities in electronic warfare, cyber, SIGINT/OSINT, and advanced R&D; the deal is expected to close in Q1 2024.